AIC
WST icon

Archer Investment Corporation’s West Pharmaceutical WST Stock Holding History

Archer Investment Corporation’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
1,003
+982
+4,676% +$300K 0.07% 237
2026
Q1 		$5.28K Hold
21
– – ﹤0.01% 918
2025
Q4 		$5.79K Hold
21
– – ﹤0.01% 833
2025
Q3 		$5.52K Hold
21
– – ﹤0.01% 850
2025
Q2 		$4.6K Hold
21
– – ﹤0.01% 854
2025
Q1 		$4.7K Buy
+21
New +$5.79K ﹤0.01% 828
2020
Q4 		– Sell
-100
Closed -$27.5K – 759
2020
Q3 		$27.5K Hold
100
– – 0.01% 329
2020
Q2 		$22.7K Sell
100
-230
-70% -$45.2K 0.01% 337
2020
Q1 		$50K Buy
330
+110
+50% +$16.9K 0.03% 233
2019
Q4 		$33K Buy
+220
New +$32K 0.02% 342

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Archer Investment Corporation's WST Position: Q2 2026 in Review

Archer Investment Corporation increased its West Pharmaceutical (WST) stake by 4,676% in Q2 2026, buying an estimated $300K and bringing the position to 1,003 shares worth $360K. The position accounts for 0.07% of the portfolio, ranked #237.

Archer Investment Corporation first reported a position in WST in Q4 2019 and has held it in 10 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Archer Investment Corporation held 1,003 shares of West Pharmaceutical worth $360K as of Q2 2026.
  • Archer Investment Corporation bought 982 West Pharmaceutical shares in Q2 2026, an estimated $300K.
  • West Pharmaceutical made up 0.07% of Archer Investment Corporation's portfolio in Q2 2026, its #237 holding.
  • Archer Investment Corporation first reported a position in West Pharmaceutical in Q4 2019 and has held it in 10 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.